Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) active agents. Its structure supports the creation of compounds with potential antidepressant, anxiolytic, and neuroprotective effects. The trifluoromethoxy group enhances metabolic stability and membrane permeability, making it valuable in drug design for improving bioavailability and target selectivity. Commonly employed in medicinal chemistry research for optimizing lead compounds in neuropharmacology.